Segment, Customer and Geographic Information

12 Months Ended

Dec. 31, 2014

Segment, Customer and Geographic Information

Note 17. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the U.S. include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the United States of America are responsible for the research and development and global and domestic commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, The Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, all of which operate in a country outside of the United States, during the years ended December 31, 2014, 2013 and 2012 (in percentages):

	Year Ended December 31,
	2014			2013			2012
Etablissement Francais du Sang		25	%		17	%		20	%
Grifols		*			18	%		19	%
Delrus Inc.		*			*			12	%

* Represents an amount less than 10% of product revenue.

Revenues by geographical location was based on the location of the customer, in the case of product revenues, and in the location of the collaboration partner, in the case of non-product revenues, during the years ended December 31, 2014, 2013 and 2012 and was as follows (in thousands):

	Year Ended December 31,
	2014		2013		2012
Product Revenue:
France	$	9,184	$	7,030	$	7,321
Spain and Portugal		2,776		7,033		7,061
CIS		6,636		8,220		8,016
Belgium		4,456		3,971		4,016
Switzerland		3,784		4,078		3,866
Other countries		9,580		9,325		6,415
Total product revenue		36,416		39,657		36,695
Government grants and cooperative agreements:
United States		0		0		91
Total government grants and cooperative agreements		0		0		91
Total revenue	$	36,416	$	39,657	$	36,786

Long-lived assets by geographical location, which consist of property and equipment, net and intangible assets, net, at December 31, 2014 and 2013, were as follows (in thousands):

	December 31,
	2014		2013
United States	$	4,624	$	3,088
Europe & other		299		445
Total long-lived assets	$	4,923	$	3,533